BTIG Research initiated coverage on Cullinan Management with a new price target
$CGEM
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
BTIG Research initiated coverage of Cullinan Management with a rating of Buy and set a new price target of $20.00